Second Messenger System

A second messenger system is an intracellular signal transduction pathway in which small, non-protein, rapidly generated molecules or ions—termed second messengers—relay and amplify signals received by cell-surface receptors from extracellular first messengers (such as peptide hormones, catecholamines, neurotransmitters, growth factors, or sensory stimuli). The conceptual paradigm of second messenger signaling was established in 1957–1958 by the American pharmacologist Earl Wilbur Sutherland Jr. and Theodore Rall, who discovered that epinephrine and glucagon stimulate hepatic glycogen breakdown without entering hepatocytes, instead triggering membrane-bound adenylyl cyclase to synthesize the heat-stable intracellular mediator 3',5'-cyclic adenosine monophosphate (cAMP)—an achievement recognized with the 1971 Nobel Prize in Physiology or Medicine.

Because water-soluble first messengers cannot passively cross the hydrophobic core of the cell membrane, transmembrane receptors—predominantly G-protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs)—transduce extracellular ligand binding across the lipid bilayer to activate membrane-associated effector enzymes or ion channels. Each activated effector enzyme synthesizes or releases thousands of second messenger molecules per second, which travel by intracellular diffusion to allosterically regulate protein kinases, phosphatases, ion channels, and transcription factors. To preserve spatial and temporal fidelity, cells restrict second messengers to discrete nanodomains and rapidly terminate signaling via degradative phosphodiesterases, lipid phosphatases, and adenosine triphosphate (ATP)-driven ion pumps.

The Receptor–Transducer–Effector Triad

In the canonical GPCR signaling architecture (elucidated by Martin Rodbell, Alfred Gilman, Robert Lefkowitz, and Brian Kobilka), an agonist-bound seven-transmembrane receptor functions as a guanine nucleotide exchange factor (GEF) for a heterotrimeric G protein composed of α, β, and γ subunits. Conformational rearrangement of the receptor catalyzes the release of GDP from the Gα subunit and the binding of cytosolic GTP (present in ~10-fold molar excess over GDP), causing GTP-bound Gα to dissociate from the Gβγ dimer. Depending on the Gα isoform family, the active subunit regulates a dedicated primary effector:

• Gα_s (stimulatory) activates transmembrane adenylyl cyclase (AC1–AC9) to synthesize cAMP.
• Gα_i/o (inhibitory) inhibits adenylyl cyclase (lowering cAMP) while its released Gβγ subunit opens G-protein-gated inwardly rectifying K⁺ (GIRK) channels to hyperpolarize the membrane.
• Gα_q/11 activates membrane-associated phospholipase C-β (PLC-β) to cleave phosphatidylinositol 4,5-bisphosphate (PIP₂).

Quantitative Signal Amplification Cascades

Second messenger cascades convert nanomolar or picomolar extracellular hormone concentrations into micromolar intracellular responses through sequential enzymatic multiplication. In epinephrine-stimulated hepatic glycogenolysis, binding of a single hormone molecule (10⁻¹⁰ to 10⁻⁸ M in plasma) to a β₂-adrenergic receptor activates roughly 10 to 20 Gα_s molecules during its brief dwell time. Each active Gα_s·GTP stimulates an adenylyl cyclase molecule that converts ATP into 10² to 10³ cAMP molecules before intrinsic GTPase activity (accelerated by Regulators of G-protein Signaling, RGS proteins) hydrolyzes GTP back to GDP. Each activated Protein Kinase A (PKA) catalytic subunit subsequently phosphorylates hundreds of phosphorylase kinase molecules, which in turn activate thousands of glycogen phosphorylase a enzymes—yielding a cumulative 10⁶- to 10⁸-fold stoichiometric amplification within seconds, releasing millimolar quantities of glucose-1-phosphate.

Cyclic Nucleotides: cAMP and cGMP

Cyclic AMP (cAMP) is synthesized from ATP via intramolecular nucleophilic attack of the 3'-hydroxyl group of ribose on the α-phosphate, releasing inorganic pyrophosphate (PP_i). In eukaryotic cells, cAMP acts on three principal effector families:

1. Protein Kinase A (PKA, cAMP-dependent protein kinase): In the resting state, PKA exists as an inactive heterotetramer (R₂C₂) consisting of a dimeric regulatory (R) subunit bound to two catalytic (C) subunits via pseudosubstrate autoinhibitory sequences. Cooperative binding of four cAMP molecules (two per R monomer) induces an allosteric conformational change that releases the active C subunits to catalyze serine/threonine phosphorylation of metabolic enzymes, ion channels, and the nuclear transcription factor CREB (cAMP response element-binding protein). Spatial specificity is maintained by A-kinase anchoring proteins (AKAPs), which tether PKA holoenzymes alongside specific phosphodiesterases (PDEs) that hydrolyze the 3'-phosphoester bond of cAMP to inactive 5'-AMP.
2. EPAC1 and EPAC2 (Exchange Proteins Directly Activated by cAMP): Guanine nucleotide exchange factors that activate the small monomeric GTPases Rap1 and Rap2 to regulate integrin cell adhesion and insulin exocytosis independently of PKA.
3. Cyclic Nucleotide-Gated (CNG) and HCN Channels: Cation channels gated directly by cAMP or cGMP in olfactory sensory neurons and sinoatrial node pacemaker cells (generating the pacemaker "funny" current I_f).

Analogously, cyclic GMP (cGMP) is synthesized from GTP by either membrane-spanning particulate guanylyl cyclases (receptors for atrial and brain natriuretic peptides, ANP and BNP) or cytosolic heme-containing soluble guanylyl cyclase (sGC), which is activated >200-fold when the gaseous messenger nitric oxide (NO) (synthesized from L-arginine by endothelial nitric oxide synthase, eNOS) binds its ferrous heme prosthetic group. Elevated cGMP activates Protein Kinase G (PKG) in vascular smooth muscle to phosphorylate myosin light-chain phosphatase and lower cytosolic Ca²⁺, causing vasodilation—the pathway targeted clinically by nitroglycerin and PDE5 inhibitors (such as sildenafil). In retinal rod and cone photoreceptors, photoactivated rhodopsin stimulates transducin (Gα_t) to activate PDE6, which rapidly hydrolyzes cGMP to close CNG Na⁺/Ca²⁺ channels and hyperpolarize the photoreceptor membrane.

The Phosphoinositide Cascade: IP3, DAG, and Lipid Messengers

When hormones or neurotransmitters (such as acetylcholine at M₁/M₃ muscarinic receptors, norepinephrine at α₁-adrenergic receptors, or angiotensin II) activate Gα_q/11—or when growth factors activate receptor tyrosine kinases coupled to SH2-domain-containing PLC-γ—activated phospholipase C hydrolyzes the minor inner-leaflet membrane phospholipid phosphatidylinositol 4,5-bisphosphate (PIP₂) into two distinct second messengers:

• Inositol 1,4,5-trisphosphate (IP₃), a water-soluble sugar phosphate headgroup that detaches from the plasma membrane and diffuses rapidly through the cytosol (D ≈ 2.8 × 10⁻¹⁰ m²·s⁻¹) to bind tetrameric IP₃ receptor (IP₃R) ligand-gated Ca²⁺ channels on the endoplasmic reticulum (ER) membrane, releasing stored Ca²⁺ into the cytosol.
• 1,2-Diacylglycerol (DAG), a hydrophobic lipid anchor that remains embedded within the inner leaflet of the cell membrane, where it acts in concert with elevated cytosolic Ca²⁺ and phosphatidylserine to recruit and activate conventional Protein Kinase C (PKC-α, β, γ) isoforms via their C1 and C2 domains.

In parallel, growth factor receptor activation of Class I Phosphoinositide 3-Kinase (PI3K) phosphorylates the 3'-hydroxyl of PIP₂ without cleaving the lipid backbone, generating the membrane-bound second messenger phosphatidylinositol 3,4,5-trisphosphate (PIP₃). PIP₃ recruits PH-domain-containing kinases (PDK1 and Akt/PKB) to the plasma membrane to drive cell survival, GLUT4 translocation, and glycogen synthesis, until the tumor suppressor lipid phosphatase PTEN dephosphorylates PIP₃ back to PIP₂.

Calcium Ions (Ca2+), Calmodulin, and Nucleotide Dinucleotides

Cytosolic free calcium ion ([Ca²⁺]_i) is the most ubiquitous ionic second messenger in eukaryotic cells. In resting cells, plasma membrane Ca²⁺-ATPases (PMCA), Na⁺/Ca²⁺ exchangers (NCX), and sarco/endoplasmic reticulum Ca²⁺-ATPases (SERCA) maintain basal cytosolic [Ca²⁺]_i near 50 to 100 nM against an extracellular concentration of ~1.2 to 2.0 mM and an ER luminal store of ~0.5 to 1.0 mM—a >10,000-fold electrochemical gradient. Opening of plasma membrane voltage-gated Ca_V channels during an action potential or opening of ER IP₃R and ryanodine receptors (RyR) (via Ca²⁺-induced Ca²⁺ release) elevates local cytosolic [Ca²⁺]_i to 1–10 μM in the form of elementary Ca²⁺ sparks, puffs, and propagating intracellular waves.

Cytosolic Ca²⁺ transients are decoded primarily by calmodulin (CaM), a 16.7-kDa dumbbell-shaped sensor protein containing four EF-hand Ca²⁺-binding motifs (K_d ≈ 0.5–5 μM). Cooperative binding of four Ca²⁺ ions exposes hydrophobic methionine-rich patches on calmodulin that wrap around target amphipathic α-helices to activate Ca²⁺/calmodulin-dependent protein kinases (CaMKI, CaMKII, CaMKIV) (essential for long-term potentiation at glutamatergic synapse sites), myosin light-chain kinase (MLCK), and the protein phosphatase calcineurin (PP2B), which dephosphorylates NFAT transcription factors during T-lymphocyte activation. In innate immunity, cytosolic double-stranded DNA activates the enzyme cGAS to synthesize the cyclic dinucleotide second messenger 2'3'-cGAMP, which binds the ER adaptor STING to induce type I interferons.

How can the same second messenger (such as cAMP) trigger different responses in different cells—or even within the same cell?

Cellular specificity arises from two mechanisms: (1) Cell-type-specific expression of receptors and downstream substrates (for example, epinephrine-induced cAMP activates glycogen phosphorylase in hepatocytes, hormone-sensitive lipase in adipocytes, and L-type Ca²⁺ channels + phospholamban in cardiomyocytes), and (2) Subcellular compartmentalization into signaling nanodomains. Rather than diffusing uniformly across the entire cell, cAMP is restricted to sub-micrometer microdomains by A-kinase anchoring proteins (AKAPs) that scaffold specific PKA isoforms directly beside localized phosphodiesterases (PDEs), which act as enzymatic "sinks" or firewalls that degrade cAMP before it can spill over into adjacent compartments.

Why is Ca2+ suited to function as an intracellular second messenger whereas Mg2+ is not?

Cells maintain cytosolic free [Ca²⁺]_i at ~100 nM (10⁻⁷ M)—four orders of magnitude lower than extracellular and ER lumen levels (~1–2 mM)—so that importing or releasing even a small number of Ca²⁺ ions increases local cytosolic concentration 10- to 100-fold within a millisecond. Moreover, the flexible coordination geometry (6 to 8 oxygen ligands) and larger ionic radius of Ca²⁺ (1.00 Å vs. 0.72 Å for Mg²⁺) allow EF-hand proteins like calmodulin to bind Ca²⁺ with 1,000-fold higher selectivity and rapid water-exchange kinetics over cytosolic free Mg²⁺, which is maintained constitutively high (~0.5–1.0 mM) as a structural counterion for ATP and nucleic acids.

How do cholera toxin and pertussis toxin disrupt GPCR second messenger signaling?

Both bacterial exotoxins are NAD⁺-dependent ADP-ribosyltransferases that covalently modify heterotrimeric Gα subunits: Cholera toxin (Vibrio cholerae) transfers an ADP-ribose group from NAD⁺ onto Arg201 of Gα_s, abolishing its intrinsic GTPase activity and locking Gα_s in a permanently active GTP-bound state that drives runaway cAMP production and CFTR Cl⁻/water secretion in intestinal enterocytes. Conversely, Pertussis toxin (Bordetella pertussis) ADP-ribosylates a C-terminal cysteine residue on Gα_i, uncoupling it from inhibitory GPCRs so that Gα_i remains locked in the inactive GDP-bound state and cannot restrain adenylyl cyclase.

1. Sutherland, E. W. (1972). "Studies on the mechanism of hormone action." Science, 177(4047), 401–408. https://doi.org/10.1126/science.177.4047.401
2. Berridge, M. J.,ipp, P., & Bootman, M. D. (2000). "The versatility and universality of calcium signalling." Nature Reviews Molecular Cell Biology, 1(1), 11–21. https://doi.org/10.1038/35036035
3. Gilman, A. G. (1987). "G proteins: Transducers of receptor-generated signals." Annual Review of Biochemistry, 56, 615–649. https://doi.org/10.1146/annurev.bi.56.070187.003151
4. Newton, A. C., Bootman, M. D., & Scott, J. D. (2016). "Second messengers." Cold Spring Harbor Perspectives in Biology, 8(8), a005926. https://doi.org/10.1101/cshperspect.a005926